Tag Archive for: Vivex Biologics

Chad Kolean Joins Vivex Biologics as Chief Financial Officer (CFO)

Life Science Partner is pleased to announce the recruitment of Chad Kolean as Vivex Biologics’ Chief Financial Officer.

Vivex Biologics is a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies. They have a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedics, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sport medicine, and wound care.

Chad Kolean

Vivex is preparing for its next stage of growth with the launch of its new product, VIA Disc. This product will be used for the treatment of Degenerative Disc Disease (DDD). As the company continues to grow in the spine and biologics industry, it sought a seasoned Chief Financial Officer who understood the landscape of this field.

Kolean previously served as the Chief Financial Officer of Titan Spine, a medical device surface technology company. One of his major milestones in preparing Titan for success was controlling and managing inventory and manufacturing challenges. His attitude helped put the company’s financial house in order.

He was also Chief Financial Officer of Cellectar Biosciences, a clinical stage biopharmaceutical company, where he restructured management and raised funds, which led to an uplisting on the NASDAQ Capital Market. Before that, Kolean served for Pioneer Surgical Technologies as their Chief Financial Officer. He was responsible for the financial aspects of leadership restructuring, development and execution, treasury, board support, investor relations, and operations.

Kolean’s arrival will provide tremendous guidance and leadership to Vivex Biologics as it prepares itself for the next stage of growth and development and the launch of a new product in the biologics space. By leveraging Kolean’s experience as a financial leader in the spine and orthopaedic industry, the company hopes for continued growth and preparation for a future financing event.  

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies.

Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Our CFO Recruitment
/0 Comments/by

Gail Farnan, MBA Joins Vivex Biologics as General Manager, Wound Care

Life Science Partner is pleased to announce the recruitment of Gail Farnan as General Manager, Wound Care for Vivex Biologics.

Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies, has developed a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedic treatments, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sports medicine, and wound care. 

The company has a robust Wound Care division that supports their Cygnus products, amniotic derived regenerative allografts used for tissue regeneration and healing.

As the company continues to grow its wide array of therapies, it needed a strategic leader who could take charge of one of their franchises. The recruitment of Farnan as General Manager, Wound Care will bring highly focused branding campaigns for the company’s sales forces.

Gail Farnan

Farnan was the Global Director of Marketing at Medtronic where she guided business development activities for a minimally invasive circulatory support platform called CircuLite. She influenced the education and training of senior leadership on the CircuLite platforms and modeled new global opportunities using qualitative and quantitative market research.

Before Medtronic, she was the Vice President of Marketing at Abiomed where she implemented new marketing strategies for the launches of their Impella platform. She was pivotal in raising U.S. market awareness and presence for the company’s corporate acquisition. Prior to Abiomed, Farnan was the Director of Global Marketing for Novoste Corporation and a Product Marketing Manager at Johnson & Johnson’s Cordis Corporation.

Farnan is a registered nurse by training who developed into a business leader that transformed the marketing landscape of the companies in her wake. Her arrival to Vivex Biologics will improve the Wound Care division with new leadership, strategies and communication tools. With this, the company plans for continued progress in the biologics space.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Executive Functions
Learn More About the Medical Device Industry
/0 Comments/by

Ron Hebert Joins Vivex Biologics as Vice President, Marketing

Life Science Partner is pleased to announce the recruitment of Ron Hebert as Vivex Biologics’ Vice President of Marketing.

Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies. They focus on orthopaedic applications with an emphasis on spine related therapies, and have developed a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedic treatments, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sports medicine, and wound care.

The next stage of the company’s growth is the launch of its new product, VIA Disc.

Ron Herbert

This viable allograft is delivered by a minimally invasive procedure and will be used for the treatment of Degenerative Disc Disease (DDD). As the company continues to grow in the spine and biologics space, it sought a talented Vice President, Marketing who could lead the branding campaigns and support the efforts of the geographic and product-focused sales forces.

Hebert was the Vice President, Marketing, Communications, and Growth Initiatives at MEDNAX, a physician-led healthcare organization that partners with hospitals and health systems to provide a wide range of clinical services. Coming into one of the largest physician-owned/operated national staffing companies, Hebert refocused the company strategy to the hospital-customer and provided them with proof of value. He also created programs that productized services such as women/children, anesthesia, and ENT/plastics specialists.

He also spent a majority of his marketing career at Beckman Coulter serving as Director of Global Strategic Marketing and Global Product Management and Strategy. Hebert’s notable accomplishment during his time here was being able to provide innovation within the traditional product portfolio of the hematology unit.

With the arrival of Hebert, Vivex will gain a marketing leader, an integrative thinker that focuses on the customer needs, a person with a demonstrated track record of successful product launches, and a strong communicator. By utilizing Hebert’s expertise in hospital-based marketing, Vivex Biologics hopes for continued growth of its new products and a skilled manager of its existing lines.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Executive Functions
/0 Comments/by

Peter Wehrly Joins Vivex Biologics as Chief Executive Officer (CEO)

Life Science Partner is pleased to announce the recruitment of Peter Wehrly as Chief Executive Officer with Vivex Biologics.

Vivex Biologics is a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies. They have a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedics, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sport medicine, and wound care. 

Peter Wehrly

Vivex is preparing for its next stage of growth with the launch of its VIA Disc product, a paradigm-changing treatment for Degenerative Disc Disease (DDD). As the company moves into the biologics space, it sought a seasoned Chief Executive to lead the company through its next stage of growth.

Wehrly is a leader in the spine and orthobiologics industries and will help lead Vivex Biologics’ expansion of their sales force and guide the company through continued growth. He is a strategic leader with a broad background in growth and operational efficiencies within public and private companies in the medical device industry. Prior to joining Vivex, Wehrly served as Chief Executive Officer with Synaptive Medical, where he led a global team launching the 2nd generation disruptive surgical robotic technology portfolio across North America, Western Europe, and Asia.

He was also Chief Executive at PQ Bypass, where he led a cross-functional team in gaining CE Mark for their Detour System, a technology designed to advance the treatment of long-segment peripheral artery disease, and approval to embark on their PMA trial in the US and Europe.

Previously, Wehrly served as Group President for Covidien where he turned around the Respiratory and Monitoring Solutions business and was later responsible for the Vascular Therapies business. Wehrly is a seasoned executive in the spine industry having led several divisions of Medtronic including Spinal and Biologics for 8 years. He played an integral role in their global market leadership positions and saw them grow from $500M to over $2.8B in compound annual growth rate.

Wehrly will play a pivotal role in helping Vivex Biologics during its next stage of growth and development as they launch a new product in the biologics space, leveraging his expertise in the spine industry and his commercial and operational strengths to ensure continued growth and preparation for a future financing event.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Executive Functions
/0 Comments/by